Dissolvable shoulder implant offers new hope for torn rotator cuffs

NCT ID NCT07208448

Disease control Sponsor: Voll Medical Technologies Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This early study is testing a new, dissolvable shoulder spacer in 20 people over 50 with large rotator cuff tears. The spacer is placed in the shoulder to reduce friction and pain. Researchers are checking if it is safe and helps improve shoulder function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: degradable shoulder spacer (implantable device)
What this could lead to: If successful, this spacer could provide a new option to relieve pain and improve shoulder function in people with large rotator cuff tears, potentially delaying or avoiding more invasive surgery.
What could go wrong: This is a very early, first-in-human study with only 20 participants. The spacer may not work as expected, could cause complications like infection or device migration, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Main Inclusion Criteria: * Full thickness MRCT. * Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits. Main Exclusion Criteria: * Documented evidence of a history of drug/alcohol abuse within 1 year of enrollment. * Concurrent participation in any other investigational clinical study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Massive rotator cuff tear are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Massive rotator cuff tear

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

4 sites in 2 countries. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Dissolvable shoulder implant offers new hope for torn rotator cuffs

What the study statuses mean